TMO / Thermo Fisher (TMO) COVID Test Sales Grow, FX Woes Persist

Thermo Fisher Scientific Inc.'s stock TMO, -7.80% fell about 9% Wednesday to put it on track for its lowest close in more than three years, after the more_horizontal

Thermo Fisher Scientific (NYSE:TMO) issued a forecast for full-year profit and sales that falls below Wall Street expectations on lower-than-expected more_horizontal

Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.69 per share, beating the Zacks Consensus Estimate of $5.58 per share. This comp more_horizontal

The leading maker of scientific equipment slashes its guidance for the second consecutive quarter, citing a challenging macro environment. more_horizontal

Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast for the second straight quarter, hurt by lower-than-expec more_horizontal

Olink Holding AB shares surged 66% to $24.87 in late-morning trading on Tuesday after the provider of next-generation proteomics solutions announced t more_horizontal

Thermo Fisher will acquire proteomics company Olink for $26 per American depositary share in cash. more_horizontal

Thermo Fisher Scientific Inc. TMO, +1.18% announced Tuesday an agreement to buy Sweden-based proteomics company Olink Holding AB OLK, +0.47% in a deal more_horizontal